Skip to content
Peptides Codex

Use the arrow keys to choose a result, Enter to open it, and Escape to close.

← Home
Synthetic α-MSH analog (melanocortin agonist)

Melanotan-1

Melanotan-1 (afamelanotide) is a synthetic tridecapeptide analog of α-melanocyte-stimulating hormone that acts on the melanocortin-1 receptor.

By The Peptides Codex Editorial TeamIndividual review date not recorded

Page data last changed: . Chemistry registry snapshot: . Registry refreshes and identity assessments are separate from scientific content review.

Length
13 aa
Class
Synthetic α-MSH analog (melanocortin agonist)
Function
Studied as a melanocortin-1 receptor agonist affecting melanin production
Context
Approved as afamelanotide for a rare photosensitivity disorder in some regions; not a tanning drug in Canada

A stabilized α-MSH analog at the center of melanocortin and pigmentation research.

Also known as: Afamelanotide · NDP-MSH · [Nle4,D-Phe7]-α-MSH · Scenesse

Part of the Cosmetic & skin peptides cluster

Overview

Melanotan-1 (afamelanotide) is a synthetic tridecapeptide analog of α-melanocyte-stimulating hormone that acts on the melanocortin-1 receptor. As afamelanotide (Scenesse) it is approved in some regions for a rare photosensitivity condition. It is not authorized as a tanning product in Canada.

Source & context

Biological / chemical source: Synthetic tridecapeptide analog of α-melanocyte-stimulating hormone

Primary research or clinical context: Approved as afamelanotide for a rare photosensitivity disorder in some regions; not a tanning drug in Canada

Structure and stability

Melanotan-1 corresponds to [Nle4,D-Phe7]-α-MSH (NDP-MSH). Substituting norleucine and a D-phenylalanine into the natural α-MSH sequence greatly increases metabolic stability and receptor potency, which is why the analog was developed for research and, later, a specific clinical indication.

Melanocortin signaling

By agonizing the melanocortin-1 receptor on melanocytes, the peptide is studied for its influence on eumelanin synthesis. Afamelanotide is approved in some jurisdictions for erythropoietic protoporphyria, a rare light-sensitivity disorder — a narrow authorized use distinct from cosmetic tanning claims.

Melanotan-1 vs Melanotan-2

A common search is melanotan-1 versus melanotan-2. They are chemically different melanocortin agonists with different receptor profiles; melanotan-2 is a smaller cyclic analog. This page compares chemistry only and does not endorse unapproved self-administration of either compound.

Sequence

One-letter sequence commonly cited for Melanotan-1 (educational; isoforms and modifications may differ):

SYSXEHFRWGKPV

SYSXEHFRWGKPV

X = non-canonical residue (N-terminal serine is acetylated; X=Nle; phenylalanine residue at position 7 is D-Phe; C-terminal valine residue is amidated). X marks a non-canonical residue — see the structure block below. (Plotted as alanine on the wheel.)

Melanotan-113 aa · C78H111N21O19 · ≈ 1,646.8 DaPEPTIDESCODEX.COMN-terminus →→ C-terminusS1Y2S3X4E−5H6F7R+8W9G10K+11P12V13nonpolarpolaracidicbasicGly / Pronon-canonical (X)Hydropathy (Kyte–Doolittle): ▮ hydrophobic (cyan) / ▮ hydrophilic (rose) · Side-chain charge at pH 7: + / −X = non-canonical residue (N-terminal serine is acetylated; X=Nle; phenylalanine residue at position 7 is D-…
Melanotan-1 — Structure cardDownload SVG
S1Y2S3A4E5H6F7R8W9G10K11P12V13
Helical wheel projection

Residues plotted ~100° apart around an α-helix — clustering of one color reveals an amphipathic face.

Analyze sequences in the playground →

Structure & chemistry

Molecular identity & reference confidence

Source-supported reference

Reference values are taken from the cited molecular record or curated profile. A database match is not independent laboratory verification; modifications, counter-ions, and formulations can change the measured mass.

Molecular form
Melanotan-1 (source record; form not independently established)
Species
Not established by this molecular identity audit
Termini (N / C)
Not specified / Not specified

Average reference mass

Reference policy updated: 2026-10-05

Molecular formula
C78H111N21O19
Average reference mass
≈ 1,646.8
Status
Approved medicine in at least one jurisdiction (IUPHAR record)
Chemical modifications (IUPHAR record)

N-terminal serine is acetylated; X=Nle; phenylalanine residue at position 7 is D-Phe; C-terminal valine residue is amidated

Identifiers

Chemistry values: IUPHAR/BPS Guide to Pharmacology, PubChem · fetched 2026-10-01.

Concentration math

Melanotan-1 — reconstitution calculator

Enter how much peptide is in the vial and how much diluent (e.g. bacteriostatic water) is added. The tool returns the resulting solution concentration — and, for any amount you type, the volume it corresponds to. This is educational arithmetic, not a dosing recommendation.

Reference form: Melanotan-1 (source record; form not independently established)Average reference mass: 1,646.8 Da

Syringe graduation
Solution concentration
5 mg/mL5,000 mcg/mL
mcg

Enter an amount to see the volume it corresponds to.

Educational concentration mathematics only. This tool does not recommend a dose, amount, or protocol, and nothing here is medical advice. Many peptides are not authorized by Health Canada for human use — see our reconstitution and bacteriostatic-water guides for context.

Open the Melanotan-1 calculator on its own page →

FAQ about Melanotan-1

What is Melanotan-1?+

Melanotan-1 (afamelanotide) is a synthetic tridecapeptide analog of α-melanocyte-stimulating hormone that acts on the melanocortin-1 receptor. As afamelanotide (Scenesse) it is approved in some regions for a rare photosensitivity condition. It is not authorized as a tanning product in Canada.

What Canadian product status is recorded for Melanotan-1?+

Canadian product status for Melanotan-1 has not been verified in this profile. No verified record here does not mean no authorization exists. Status depends on the product, formulation and use; consult Health Canada's product records.

What is the typical length of Melanotan-1?+

Melanotan-1 is commonly described as approximately 13 amino acids (Synthetic α-MSH analog (melanocortin agonist)).

Related peptides

References & further reading

  1. 1.Polańska et al. (2024). Afamelanotide in protoporphyria and other skin diseases: a review. Postepy Dermatol Alergol
  2. 2.Kim et al. (2016). Afamelanotide: A Review in Erythropoietic Protoporphyria. Am J Clin Dermatol
  3. 3.Langendonk et al. (2015). Afamelanotide for Erythropoietic Protoporphyria. N Engl J Med
  4. 4.Wensink et al. (2021). Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria. Expert Rev Clin Pharmacol
  5. 5.Wu et al. (2021). Afamelanotide: An Orphan Drug with Potential for Broad Dermatologic Applications. J Drugs Dermatol
  6. 6.Kluijver et al. (2024). The effects of cholecalciferol and afamelanotide on vitamin D levels in erythropoietic protoporphyria: a multicentre cohort study. Br J Dermatol
  7. 7.Minder et al. (2017). Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders. Clin Pharmacokinet
  8. 8.Minder (2010). Afamelanotide, an agonistic analog of α-melanocyte-stimulating hormone, in dermal phototoxicity of erythropoietic protoporphyria. Expert Opin Investig Drugs
  9. 9.PubChem — compound summary for Afamelanotide (CID 16197727)
  10. 10.Wikipedia — Afamelanotide
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Melanotan-1 educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.